INS and Hypoglycemia: In the trial by Ferguson and the HypoAna and HypoDeg trials, insulin doses were adjusted individually according to baseline HbA1c to avoid imposing further hypoglycemia risk on the participants by applying a titration regimen while also resembling everyday clinical practice more (Kristensen et al., 2012b; Agesen et al., 2019).